CHIP-AML22/Quizartinib: Quizartinib + Chemotherapy in Newly Diagnosed Pediatric FLT3-ITD+ and NPM1wt AML Patients

Conditions: Acute Myeloid Leukemia in Children Interventions: Drug: Quizartinib; Drug: Etoposide; Drug: Dexrazoxane; Drug: Mitoxantrone; Drug: Cytarabine; Drug: Methotrexate; Drug: Daunorubicin; Drug: Fludarabine; Other: allo-SCT Sponsors: Princess Maxima Center for Pediatric Oncology; Daiichi Sankyo Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials